3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
13
Sarcoma
10
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Melanoma
17
Lung Neoplasms
6
Head and Neck Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Kidney Neoplasms
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Skin Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Sezary Syndrome
2
Sarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Temozolomide
2
Psychiatric Rehabilitation
2
Paclitaxel
2
Early Intervention, Educational
2
sargramostim
1
regorafenib
1
pentetreotide
1
pembrolizumab
1
pazopanib
1
imetelstat
1
glutathione pegylated liposomal doxorubicin
1
durvalumab
1
carboxyamido-triazole
1
cabozantinib
1
binimetinib
1
aflibercept
1
Trastuzumab
1
Thiotepa
1
Surveys and Questionnaires
1
Radiotherapy
1
Quality of Life
1
Positron-Emission Tomography
1
Pemetrexed
1
Patient Reported Outcome Measures
1
PF-07284890
1
Oxycodone
1
Nivolumab
1
NEO212
1
Morphine
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Drug Therapy
×
Dermatologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled